CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $HIND–Vyome Holdings, Inc. (Nasdaq: HIND) (“Vyome”), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today congratulated its Scientific Co-Founder and Director, Dr. Shiladitya Sengupta, PhD, on his promotion to Professor of Medicine at Harvard Medical School. The academic recognition marks an important milestone in Dr. Sengupta’s distinguished scientific career, spanning biomedical research, nanomedicine, bioeng
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
